You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 2, February 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carbamazepine and Haloperidol v Placebo and Haloperidol in Excited Psychoses

A Controlled Study

Ehud Klein, MD; Efraim Bental, MD; Bernard Lerer, MD; Robert H. Belmaker, MD

Arch Gen Psychiatry. 1984;41(2):165-170.


Abstract

• Carbamazepine has recently been reported to have therapeutic potential in mania. We studied carbamazepine plus haloperidol v placebo plus haloperidol in excited psychoses in a controlled double-blind design. Twenty-three patients completed five weeks of carbamazepine-haloperidol therapy, and 20 patients placebo-haloperidol therapy. Brief Psychiatric Rating Scale ratings showed superior improvement in the group receiving carbamazepine plus haloperidol. This benefit was as apparent in excited schizophrenia as in mania. No unusual toxicity was observed because of the combination of haloperidol with carbamazepine.



Author Affiliations

From the Jerusalem Mental Health Center—Ezrath Nashim.


Footnotes

Accepted for publication April 25, 1983.

Reprint requests to Jerusalem Mental Health Center—Ezrath Nashim, PO Box 140, Jerusalem 91001, Israel (Dr Belmaker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atypical antipsychotics in bipolar disorder: the treatment of mania
Cookson
Adv. Psychiatr. Treat. 2008;14:330-338.
ABSTRACT | FULL TEXT  

Phenytoin as an Antimanic Anticonvulsant: A Controlled Study
Mishory et al.
Am. J. Psychiatry 2000;157:463-465.
ABSTRACT | FULL TEXT  

Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol
Hernandez-Avila et al.
Psychiatr. Serv. 1998;49:812-815.
ABSTRACT | FULL TEXT  

The Use of Anticonvulsants in Psychiatry
Gaulin
Journal of Pharmacy Practice 1996;9:104-112.
ABSTRACT  

The Pharmacotherapy of Human Aggression: A Review
Caley
Journal of Pharmacy Practice 1996;9:133-143.
ABSTRACT  

In vivo effects of carbamazepine and haloperidol on GABA neurotransmission and LH secretion
Wolf et al.
J Psychopharmacol 1995;9:25-31.
ABSTRACT  

Carbamazepine Compared With Lithium in the Treatment of Mania
Small et al.
Arch Gen Psychiatry 1991;48:915-921.
ABSTRACT  

Carbamazepine Maintenance Treatment in Outpatient Schizophrenics
Carpenter et al.
Arch Gen Psychiatry 1991;48:69-72.
ABSTRACT  

Dopaminergic Effects of Carbamazepine: Relationship to Clinical Response in Affective Illness
Post et al.
Arch Gen Psychiatry 1986;43:392-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.